These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 31166078)

  • 1. Novel BQCA- and TBPB-Derived M
    Schramm S; Agnetta L; Bermudez M; Gerwe H; Irmen M; Holze J; Littmann T; Wolber G; Tränkle C; Decker M
    ChemMedChem; 2019 Jul; 14(14):1349-1358. PubMed ID: 31166078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.
    Jones CK; Brady AE; Davis AA; Xiang Z; Bubser M; Tantawy MN; Kane AS; Bridges TM; Kennedy JP; Bradley SR; Peterson TE; Ansari MS; Baldwin RM; Kessler RM; Deutch AY; Lah JJ; Levey AI; Lindsley CW; Conn PJ
    J Neurosci; 2008 Oct; 28(41):10422-33. PubMed ID: 18842902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation.
    Canals M; Lane JR; Wen A; Scammells PJ; Sexton PM; Christopoulos A
    J Biol Chem; 2012 Jan; 287(1):650-659. PubMed ID: 22086918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the binding site of novel selective positive allosteric modulators at the M
    Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
    Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further exploration of M₁ allosteric agonists: subtle structural changes abolish M₁ allosteric agonism and result in pan-mAChR orthosteric antagonism.
    Sheffler DJ; Sevel C; Le U; Lovell KM; Tarr JC; Carrington SJ; Cho HP; Digby GJ; Niswender CM; Conn PJ; Hopkins CR; Wood MR; Lindsley CW
    Bioorg Med Chem Lett; 2013 Jan; 23(1):223-7. PubMed ID: 23200253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.
    Bridges TM; Brady AE; Kennedy JP; Daniels RN; Miller NR; Kim K; Breininger ML; Gentry PR; Brogan JT; Jones CK; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5439-42. PubMed ID: 18805692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity.
    Marlo JE; Niswender CM; Days EL; Bridges TM; Xiang Y; Rodriguez AL; Shirey JK; Brady AE; Nalywajko T; Luo Q; Austin CA; Williams MB; Kim K; Williams R; Orton D; Brown HA; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2009 Mar; 75(3):577-88. PubMed ID: 19047481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M
    Jörg M; van der Westhuizen ET; Khajehali E; Burger WAC; White JM; Choy KHC; Tobin AB; Sexton PM; Valant C; Capuano B; Christopoulos A; Scammells PJ
    ACS Chem Neurosci; 2019 Mar; 10(3):1099-1114. PubMed ID: 30547573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding mode.
    Digby GJ; Utley TJ; Lamsal A; Sevel C; Sheffler DJ; Lebois EP; Bridges TM; Wood MR; Niswender CM; Lindsley CW; Conn PJ
    ACS Chem Neurosci; 2012 Dec; 3(12):1025-36. PubMed ID: 23259038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photo-BQCA: Positive Allosteric Modulators Enabling Optical Control of the M1 Receptor.
    Gerwe H; Schaller E; Sortino R; Opar E; Martínez-Tambella J; Bermudez M; Lane JR; Gorostiza P; Decker M
    Angew Chem Int Ed Engl; 2024 Aug; ():e202411438. PubMed ID: 39136071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.
    Miller NR; Daniels RN; Bridges TM; Brady AE; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5443-7. PubMed ID: 18829311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias.
    van der Westhuizen ET; Choy KHC; Valant C; McKenzie-Nickson S; Bradley SJ; Tobin AB; Sexton PM; Christopoulos A
    Front Pharmacol; 2020; 11():606656. PubMed ID: 33584282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion and Oligomerization States of the Muscarinic M
    Zhou X; Septien-Gonzalez H; Husaini S; Ward RJ; Milligan G; Gradinaru CC
    J Phys Chem B; 2024 May; 128(18):4354-4366. PubMed ID: 38683784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing drugs and chemical probes with the dualsteric approach.
    Zha J; He J; Wu C; Zhang M; Liu X; Zhang J
    Chem Soc Rev; 2023 Dec; 52(24):8651-8677. PubMed ID: 37990599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Study in MPO and Molecular Docking of the Synthetic Drynaran Analogues Against the Chronic Tinnitus: Modulation of the M1 Muscarinic Acetylcholine Receptor.
    da Rocha MN; da Fonseca AM; Dantas ANM; Dos Santos HS; Marinho ES; Marinho GS
    Mol Biotechnol; 2024 Feb; 66(2):254-269. PubMed ID: 37079267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybridization into a Bitopic Ligand Increased Muscarinic Receptor Activation for Isopilocarpine but Not for Pilocarpine Derivatives.
    Heinz CS; Bermudez M; Jaiswal N; Große C; Kauk M; Hoffmann C; Holzgrabe U
    J Nat Prod; 2023 Apr; 86(4):869-881. PubMed ID: 37042802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the operational model of agonism of receptor dimers.
    Jakubík J; Randáková A
    Expert Opin Drug Discov; 2022 Nov; 17(11):1181-1191. PubMed ID: 36369915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease.
    Chintamaneni PK; Krishnamurthy PT; Pindiprolu SKSS
    RSC Adv; 2021 Jan; 11(10):5325-5334. PubMed ID: 35423107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs.
    Egyed A; Kiss DJ; Keserű GM
    Front Pharmacol; 2022; 13():847788. PubMed ID: 35355719
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.